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Proteins of the LIM family are critical regulators of development and differentiation in various cell types. Here we examined the roles of
one new member of LIM family, hhLIM, in cardiac hypertrophic growth and cardiac muscle-specific gene expression. To model the increase
in endogenous hhLIM transcriptional activity that occurs in response to hypertrophic stimulation, hhLIM was overexpressed using a
recombinant plasmid for hhLIM. The results showed that overexpression of hhLIM resulted in increased cell volume in both C2C12 muscle
cells (>1.5-fold) and cardiac myocytes (>2.49-fold), a phenotype commonly associated with cardiac hypertrophy. RT-PCR and Western blot
showed that transfection of hhLIM into C2C12 muscle cells and cardiomyocytes increased skeletal a-actin levels and triggered the
expression of the embryonic-related gene BNP, which is associated with cardiac hypertrophy. Inhibition of hhLIM expression by antisense
transcripts blocked the induction of skeletal a-actin and BNP expression by endothelin-1. These data indicated that hhLIM played a role in
regulation of cardiomyocyte growth and cell size in response to hypertrophic stimuli through its modulation of skeletal a-actin and BNP
expression. We also determined by confocal laser scanning microscopy and immunoprecipitation that hhLIM was associated with a-actin and
localized in the cytoplasm in unstimulated cells, and was relocalized from the cytoplasm to the nucleus upon hypertrophic stimulation. These
studies suggest that hhLIM protein is involved in cardiac hypertrophy.
D 2004 Elsevier B.V. All rights reserved.Keywords: hhLIM gene; Cardiomyopathy; C2C12 cell; Skeletal a-actin; BNP1. Introduction
Recent clinical studies have suggested that cardiac hy-
pertrophy is an independent risk factor of cardiac morbidity
and mortality [1]. Therefore, it is important to determine the
mechanism of how cardiac hypertrophy develops. Hypertro-
phic growth is one of the ways the heart adapts to a variety of
pathological stimuli, including hypertension, myocardial
infarction, endocrine disorders, and perturbations in sarco-
meric function due to altered expression or mutation of
contractile protein genes. Cardiomyocyte hypertrophy can
be induced by a variety of factors such as mechanical stress
and vasoactive materials, including catecholamines, angio-0925-4439/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
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E-mail address: wjk@hebmu.edu.cn (J.-K. Wen).tensin II, endothelin-1, and cytokines [2]. We and others
have reported that mechanical stress induces cardiomyocyte
hypertrophy through vasoactive peptides such as angiotensin
II and endothelin-1 [3]. In response to hypertrophic signals,
cardiomyocytes activate a cellular response characterized by
an increase in cell size and sarcomere assembly, induction of
fetal cardiac genes, and repression of genes encoding the
corresponding adult isoforms.
The LIM domain is a cysteine-rich zinc-finger motif
found in a large family of proteins [3]. Proteins containing
LIM domains have been linked with a variety of funda-
mental biological events including cytoskeletal organiza-
tion, cell lineage specification and organ development [4].
Biochemically, the LIM domains are responsible for key
interactions with co-activators, co-repressors, competitors,
and other transcription factors, and are therefore of consid-
erable importance for the regulation of associated transcrip-
tional activities [4]. Recently, a new member of the LIM
family, named hhLIM (also known as hLIM3, GenBank
AF121260), was cloned by three elements PCR-select
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recent years, accumulating results have continued to attri-
bute essential functions to LIM proteins in a variety of
different biological processes. But little is known about the
new gene hhLIM. We have identified that hhLIM transcripts
were detected in cardiac cell progenitors during embryo-
genesis, indicating that hhLIM gene is tightly linked to
cardiomyocyte specification. We also found that hhLIM
RNA level increased in pressure-induced cardiac hypertro-
phy and that hhLIM protein played a role as an effector of
hypertrophic response. But it is not clear whether hhLIM
acts directly as a necessary sufficient mediator of the
response. In the present study we provide further evidence
linking hhLIM to the hypertrophic response and show that
hhLIM is sufficient for inducing cardiomyocyte hypertro-
phy in cultured myoblasts. In addition, ours is the first
report that hhLIM protein location changes from cytoplasm
to nucleus in response to stimuli inducing differentiation
and hypertrophy.2. Materials and methods
2.1. Cell culture
The muscle-derived cell line C2C12 myoblasts (ATCC,
CRL1772) were cultured in growth medium (Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf
serum) (MB). To induce myogenic differentiation, subcon-
fluent cultures were shifted to differentiation medium (Dul-
becco’s modified Eagle’s medium supplemented with 2%
horse serum) (MT).
2.2. RNA isolation and RT-PCR
Total cellular RNA was isolated by guanidine isothio-
cyanate [6]. Semi-quantitative RT-PCR was performed
with gene-specific primer pairs for hhLIM and BNP
cDNA. The sequences for hhLIM and BNP cDNA were
obtained from GenBank AF121260, D16497). The specific
primer sets for hhLIM and BNP were: hhLIM, forward
primer 5V-GCTGTCTCAGCACAGACA-3V and reverse
primer 5V-ATGGCACAGCGGA-3V; BNP, forward primer
5V-GCTGCTGGAGCTGATAAG-3V and reverse primer 5V-
TTTGAGGTCTCTGCTGGA-3V. The level of transcription
for the constitutive housekeeping gene, GAPDH, was
quantitatively measured in each sample to control differ-
ences in RNA concentrations. The data were analyzed by
Bio 1D software (Kodak).
2.3. Western blot analysis
Cells were harvested and protein extracts were prepared
in RIPA buffer (1% NP40, 1% SDS, 150 mM NaCl, 50 mM
Tris–HCl, pH 7.5, 10% glycerol, 1 mM NaVO3, 1 mM
PMSF) as described previously [7]. Protein concentrationwas determined by a modified Lowry protein assay. Fifty-
microgram protein per sample was separated by polyacryl-
amide gel electrophoresis, transferred to nitrocellulose
membrane and blocked in 5% milk/TTBS (500 mM NaCl,
0.05% Tween 20, 50 mM Tris–HCl, pH 7.5). Membranes
were incubated overnight at 4 jC with a mouse monoclonal
antibody specific to skeletal a-actin (Sigma), then incubated
with an alkaline phosphatase-conjugated secondary anti-
body. Bands were detected by chemiluminescence (Visa
ECF, Amersham Pharmacia Biotech).
2.4. Plasmids and construction
The hhLIM expression plasmid (pX) was a gift from Dr.
Chen Kuang-hui [5] that was constructed by subcloning the
hhLIM cDNA into the pcDNA2 vector. The hhLIM/lucifer-
ase reporter plasmid (phL) was constructed by ligation of
PCR-amplified hhLIM upstream DNA fragment ( 537 to
+ 16 bp) to the promoterless luciferase reporter vector (pGL-
Basic) (Promega) [7]. The hhLIM fusion plasmid (phF) was
constructed by inserting a complete hhLIM cDNA fragment
into pEGFP-C3 vector. An antisense hhLIM plasmid (phA)
was constructed by inserting the hhLIM cDNA into pEGFP-
N1 plasmid. pCMV-IGF-1 was a gift from Dr. Pietrzkowski
(Jefferson Medical College) [8]. The BNP/luciferase repor-
ter plasmid was a gift from Dr. Gardner (University of
California) [9].
2.5. Transfection and determination of reporter activity in
C2C12 cells
Plasmids were prepared for transfection using Wizard Sv
96 plasmid DNA purification system (Promega). C2C12
cells were grown up to 70% confluence in 60-mm culture
dishes, and transiently transfected with 1 Ag of hhLIM
promoter plasmid (phL) together with 1 Ag of h-galactosi-
dase vector (pCMVgal, Promega) using ESCORTk Trans-
fection Reagent (Sigma). Cells were incubated for 16 h in
DMEM +10% FCS and then placed in DMEM containing
2% horse serum with or without endothelin-1 (110 7 M)
for 48 h. Cells were then harvested and the luciferase and h-
galactosidase activities were measured by a liquid scintilla-
tion counting-based assay following the manufacturer’s
instructions (Promega).
2.6. Cell size measurement and intracellular distribution of
hhLIM protein
C2C12 cells were grown up to 70% confluence and
transiently co-transfected with 1 Ag of hhLIM expression
plasmid (pX) and 0.5-Ag pEGFP-N1. After transfection cells
were placed in DMEM containing 2% horse serum for 48 h.
For cell size measurement, 10 or 20 randomly chosen 400-
fold magnification fields were visualized by phase contrast
and photographed. From these photos, cell surface of 100
randomly selected individual cells was measured by planim-
B. Zheng et al. / Biochimica et Biopetry. C2C12 cells were transfected with hhLIM-GFP fusion
plasmid (phF) as described above and then incubated in
DMEM containing 2% horse serum for 24, 48, and 72 h.
Distribution of hhLIM protein was detected using fluores-
cent microscopy.
2.7. Immunofluorescence
Cells were fixed on the coverslips with 4% paraformal-
dehyde for 30 min at room temperature. These fixed cells
were blocked with a solution of 1% BSA and then incubated
overnight at 4 jC with antibodies against skeletal a-actin
(1:100) (Sigma) and hhLIM (1:100) (a gift from Dr. Chen
Kuang-hui, Peking University) [5]. FITC and TRITC con-
jugated secondary antibodies were used at 1:100 for 2 h at
room temperature. Stained cells were observed with a Leica
DMRE confocal laser-scanning microscope (Leica Micro-
systems, Heidelberg, Germany).
2.8. Co-immunoprecipitation of hhLIM and a-actin
Cells were collected and lysed in lysis buffer (50 mM
Tris–HCl, pH 7.5, 150 mM NaCl, 0.1% SDS, 1 mM PMSF,
1% NP40, 0.5% deoxycholate) on ice for 30 min, and then
centrifuged at 12000 g at 4 jC. To immunoprecipitate
proteins, the supernatant was incubated with 20-Al anti-
hhLIM antibody conjugated to agarose beads (1.8 mg
antibody/ml) in a total volume of 0.5 ml and rocked
continuously overnight at 4 jC. The beads were then
pelleted, washed five times in lysis buffer, suspended in
2 Laemmli buffer, and subjected to Western blot analysis
for a-actin as described above [10].Fig. 1. Skeletal a-actin protein, BNP and hhLIM gene expression in C2C12 ce
confluence and washed with Hanks balanced salt solution before incubation for 6,
110 7 M endothelin-1. Western blot and RT-PCR analysis for a-actin (A), BNP
were assayed in triplicate. 1–6: C2C12 cells (MT) treated by endothelin-1 for 0,2.9. Primary cardiomyocyte cultures
Primary cardiomyocytes were cultured as described pre-
viously [2]. Briefly, 1-day-old mouse neonates were sacri-
ficed by CO2 inhalation, the heart was collected, atria were
removed, and the ventricles were cut into four pieces and
digested using 0.05% pancreatin and 0.1% collagenase.
Then the cells were plated on gelatinized cell culture dishes
and cultured overnight in DMEM supplemented with 15%
FCS and penicillin/streptomycin (100 units/ml) [2].
2.10. Statistical analysis
Each experiment was performed in triplicate. All data
presented are meansF S.E. Results were analyzed using a t-
test for nonpaired and paired variates.
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3.1. hhLIM gene expression was augmented by endothelin-1
To assess the progression of hypertrophy of C2C12 cells
(MT) induced by endothelin-1, the hypertrophic marker
BNP and skeletal a-actin were analyzed by RT-PCR and
Western blot analysis. As analyzed by Western blot, skeletal
a-actin protein level in cultured C2C12 cells (MT) progres-
sively increased with duration of endothelin-1 treatment
(Fig. 1A). BNP gene expression could not be detected in
untreated C2C12 cells (MT), but was significantly induced
by endothelin-1 stimulation (Fig. 1B). These results show
that endothelin-1 is a good hypertrophic stimulus. Tolls (MT) treated by endothelin-1. C2C12 cells (MT) were grown to 70%
12, 24, 48, and 72 h in DMEM containing 2% horse serum with or without
(B) or hhLIM (C, D) were performed under Materials and methods. Samples
6, 12, 24, 48, and 72 h.
Fig. 3. Effect of hhLIM overexpression on C2C12 cells in size. C2C12 cells
(MT) were co-transfected with hhLIM expression plasmid (pX) and
pEGFP-N1 and the images were detected using fluorescent microscopy (A),
pCMV-gal and pEGFP-N1 co-transfected the cells as a control (B). (For
color see online version).
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we examined whether expression of hhLIM was altered by
hypertrophic stimuli. As shown in Fig. 1C and D, treatment
of cultured C2C12 cells (MT) with endothelin-1 for 6, 12,
24, 48, and 72 h increased hhLIM mRNA levels with a peak
induction after 24 h (4.5-fold over control, P < 0.05).
To examine the transcriptional responsiveness of hhLIM
to a hypertrophic agonist, C2C12 cells (MT) were transient-
ly transfected with a luciferase reporter containing the
hhLIM promoter (phL). Transfection of the phL, together
with endothelin-1 stimulation, caused a 1.56-fold increase in
luciferase activity as compared to the control (P < 0.05)
(Fig. 2), showing that endothelin-1 can augment transcrip-
tion of the hhLIM promoter.
3.2. Overexpression of hhLIM induced C2C12 cell hyper-
trophy in culture
The above data suggested that hhLIM is an important
factor in the hypertrophic response of C2C12 cells (MT).
However, we still did not know whether hhLIM plays a
direct role in triggering cellular hypertrophy. To test this we
studied whether hhLIM overexpression is sufficient to
bypass upstream signaling events and initiate the hypertro-
phic response. Accordingly, C2C12 cells (MT) transfected
with hhLIM expression plasmid (pX), which constitutively
express hhLIM or pCMV-gal (as a control), were examined
for morphological and biochemical features of hypertrophy
24 to 48 h later. The data demonstrated that hhLIM induced
a striking hypertrophic response characterized by increased
cell size in both the long and short cellular axes. At 48 h after
transfection, hhLIM overexpression increased cell surface
area by more than 150% as compared with h-gal (P < 0.05)
(Fig. 3A and B). Collectively, the data indicate that hhLIM
is sufficient for hypertrophic induction in cultured C2C12
cells (MT).
We also set out to determine whether hhLIM is capable
of activating expression of the hypertrophic markers, BNPFig. 2. Effects of endothelin-1 on hhLIM promoter activation. C2C12 cells
(MT) were transfected with constructs (phL) possessing the 5V flanking
sequence of hhLIM gene ligated to luciferase, plated for 24 or 48 h with
endothelin-1 treatment. *P< 0.05 comparedwith group transfectedwith phL.and skeletal a-actin. Expression of BNP was undetected in
C2C12 cells (MT) grown in 2%horse serum, but BNPmRNA
in these differentiated cells was elevated 48 h after transfec-
tion of the hhLIM expression plasmid (pX) (Fig. 4A and B).
Western blot analysis showed that overexpression of hhLIM
caused a 50% increase in skeletal a-actin protein levels in
C2C12 cells (MT) as compared with those transfected with
empty vector alone (Fig. 4C andD).Although skeletala-actin
proteinwas undetectable in C2C12 cells (MB), transfection of
hhLIM could induce this protein expression, to a certain
extent, in these cells. These results showed that hhLIM alone,
when overexpressed, was capable of inducing hypertrophy in
C2C12 cells (MT) and might be doing so through transcrip-
tional activation of hypertrophic factors.
3.3. Intracellular distribution of hhLIM protein in C2C12
cells
To determine the subcellular distribution of hhLIM, cells
were incubated in DMEM containing 2% horse serum for
24, 48, and 72 h after transfection with GFP-hhLIM fusion
plasmid (phF). The results indicated that cells expressing
GFP alone showed a diffuse fluorescence pattern with
uniform intensity throughout the cells (Fig. 3B), consistent
with its known distribution in both cytoplasmic and nuclear
compartments. Although C2C12 cells (MT) expressing the
GFP-hhLIM fusion protein initially displayed a similar
diffuse pattern of fluorescence, the fluorescent signal be-
came more concentrated in the cytoplasm as the time of
post-transfection increased (Fig. 5A–C). These results in-
dicated that hhLIM protein was localized in both the
cytoplasm and the nucleus in exponentially growing
C2C12 cells (MT).
We also wanted to confirm these results in cells that
naturally express hhLIM. For this purpose, anti-hhLIM
immunofluorescence assay was performed on C2C12 cells
(MT) before and after treatment with endothelin-1 for
different durations. In the absence of stimulation, hhLIM
Fig. 4. BNP mRNA and skeletal a-actin expression in C2C12 cells. C2C12 cells (MB) were grown up to 70% confluence and transiently co-transfected with 1
Ag of hhLIM expression plasmid (pX) and 0.5-Ag pEGFP-N1. After transfection, cells were placed in DMEM containing 2% horse serum for 48 h. BNP
mRNA (A, B) and skeletal a-actin (C, D) in C2C12 cells were analyzed by RT-PCR and Western blot analysis. 1, 6: pcD2-hhLIM (pX)-transfected MT; 2:
pcD2-transfected MT treated by endothelin-1; 3, 8: pcD2-transfected MT; 4: pcD2-hhLIM (pX)-transfected MB; 5: pCMV-IGF-1-transfected MT; 7: pcD2-
transfected MB. *P < 0.05 compared with pcD2-transfected C2C12 cells (MB and MT).
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(results not shown). Interestingly, when C2C12 cells (MT)
were induced by endothelin-1, hhLIM protein was found to
accumulate in the nuclei, to the greatest extent at 24 h after
treatment and to a somewhat reduced level after longerFig. 5. Subcellular localization of hhLIM protein in C2C12 cells. C2C12 cell
fluorescence of GFP-hhLIM fusion protein in C2C12 cells after 24 (A), 48 (B), an
cells were grown on coverslips in six-well plates in the presence of DMEM contain
2% horse serum plus 110 7 M endothelin-1. Subcellular localization of endoge
for 24 h (D) and 48 h (E) was detected with immunofluorescence analysis. (Fortreatments (Fig. 5D and E). These results show that hhLIM
enters the nucleus and that temporal nuclear accumulation of
hhLIM after hypertrophic stimuli corresponds with timing of
BNP induction, suggesting that hhLIM may be relevant for
activating cell hypertrophy.s were transfected with GFP-hhLIM fusion protein plasmid (phF). GFP
d 72 (C) h, respectively, was displayed by fluorescent microscopy. C2C12
ing 2% horse serum for 48 h and then switched to fresh DMEM containing
nous hhLIM protein in C2C12 cells (MT) after treatment with endothelin-1
color see online version).
Fig. 7. hhLIM and BNP mRNA expression in cardiac myocytes. Primary
cardiomyocytes were treated by endothelin-1 for 48 h, hhLIM gene
expression was analyzed by RT-PCR (A). Cardiomyocytes were grown to
70% confluence and transfected with 1 Ag of hhLIM expression plasmid
(pX). After transfection, cells were incubated in DMEM containing 10%
FCS for 48 h. BNP gene expression was analyzed by RT-PCR (B).
Biophysica Acta 1690 (2004) 1–103.4. Interaction between a-actin and hhLIM in C2C12 cells
Many previous reports have shown that some LIM
proteins play a role in fundamental biological processes,
such as cytoskeletal organization. From the above data, we
know that hhLIM protein was distributed in the C2C12
cytoplasm at 48 h after transfection. To test whether the
cytoplasmic hhLIM could interact with a-actin, we carried
out co-immunoprecipitation using an anti-hhLIM antibody-
linked to agarose beads, and the resulting precipitate was
analyzed by Western blot analysis using an anti-a-actin
antibody. As expected, a-actin was found to co-precipitate
with hhLIM (Fig. 6A and B). a-Actin is expressed in the
cells at a very high level and is notoriously known to bind
to many proteins nonspecifically. In order to testify the
specificity of interaction between hhLIM and a-actin, 3–6-
fold excess of negative control (BSA) was added 15 min
before addition of anti-hhLIM antibody in competition
assay. The results showed that excess amount of BSA
could not affect the specific interaction between hhLIM
and a-actin. When we examined whether endogenous
hhLIM protein induced by endothelin-1 could also interact
with a-actin by immunofluorescence and confocal micros-
copy, it was found that hhLIM did associate with a-actin
(Fig. 6C), showing that their interactions do have physio-
logical relevance.
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endothelin-1. C2C12 cells were grown up to 70% confluence, and transiently tra
cells were placed in DMEM containing 2% horse serum or 10% FCS for 48 h.
antibody conjugated to agarose beads. Beads were pelleted, washed, and subsequ
plasmid-transfected cells as a control (A, B). Double immunofluorescence of hhL
h (C). 1: pcD2-transfected MT; 2: pcD2-hhLIM (pX)-transfected MT; 3: pcD2
transfected MB. (For color see online version).3.5. Overexpression of hhLIM induced cardiac myocyte
hypertrophy in culture
To further investigate the role of hhLIM as cardiac
hypertrophic regulator, we examined whether endothelin-1
stimulation affects expression of endogenous hhLIM in
cardiac myocytes. As analyzed by RT-PCR, treatment of
cultured cardiomyocytes with endothelin-1 for 48 h up-
regulated hhLIM gene expression (2.12-fold over control,and localization of a-actin and hhLIM in C2C12 cells (MT) treated by
nsfected with 1 Ag of hhLIM expression plasmid (pX). After transfection,
The whole lysate was subjected to immunoprecipitation with anti-hhLIM
ently analyzed by Western blot analysis using anti-a-actin antibody, pcD2
IM and a-actin is overlaid in C2C12 cells treated by endothelin-1 for 24
-hhLIM (pX)-transfected MB; 4: pCMV-IGF-1-transfected MT; 5: pcD2-
Fig. 8. Effect of hhLIM overexpression on BNP promoter activation.
Luciferase activities of cardiac myocytes co-transfected with BNP promoter
reporter and hhLIM expression plasmid (pX) were analyzed by a liquid
scintillation counting-based assay. Cardiac myocytes transfected with BNP
promoter reporter and induced with endothelin-1 as a positive control.
*P < 0.05 compared with BNP promoter reporter transfected cardiac
myocytes.
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BNP gene was undetected in untreated cardiac myocytes,
but was dramatically induced by endothelin-1 stimulation
(Fig. 6B). These data demonstrated that endothelin-1 stim-
ulation of cardiomyocytes could increase expression of bothFig. 9. BNP mRNA and skeletal a-actin expression in cardiac myocytes transfec
were grown to 70% confluence and transfected with 1 Ag of hhLIM expression pl
gene expression and skeletal a-actin protein level were analyzed by RT-PCR andhhLIM and BNP, thus linking these two genes to hypertro-
phic response.
To investigate whether hhLIM is sufficient to bypass
upstream signaling events and is capable of initiating the
hypertrophic response, cardiomyocytes transfected with
hhLIM expression plasmid (pX) were examined for mor-
phological and biochemical features of hypertrophy 48
h after transfection and compared to those transfected with
the control vector, pCMV-h-gal. The data demonstrated that
hhLIM overexpression induced a striking hypertrophic
response characterized by increased cell size in both the
long and short cellular axes (data not shown). Overexpres-
sion of hhLIM also induced expression of BNP (Fig. 7B)
and skeletal a-actin protein (data not shown).
To examine the transcriptional responsiveness of BNP
gene to hhLIM protein, cardiac myocytes were transiently
co-transfected with a luciferase reporter directed by the BNP
promoter ( 1595 bp) and hhLIM expression plasmid (pX).
As shown in Fig. 8, their co-transfection resulted in 3.96-
fold activation of luciferase activity as compared to untrans-
fected controls (P < 0.05), suggesting that hhLIM couldted with an antisense hhLIM expression plasmid. Primary cardiomyocytes
asmid (pX) and 1 Ag of hhLIM antisense plasmid (phA), respectively. BNP
Western blot.
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also augmented expression of the BNP promoter to a same
extent as hhLIM overexpression. In addition, individual
expression vector for hhLIM or Nkx2.5 could enhance
BNP reporter expression in cardiac myocytes. Co-transfec-
tion of hhLIM and Nkx2.5 produced additive luciferase
expression (data not shown). Collectively, these results
indicate that hypertrophic stimuli induce hhLIM expression
and its trans-activation capability, and this activation corre-
lates with induction of the downstream hypertrophic effec-
tors BNP and skeletal a-actin.
3.6. Antisense hhLIM blocked the hypertrophic response in
culture
To determine whether endogenous hhLIM act as essential
hypertrophic transcriptional effectors, antisense hhLIM ex-
pression plasmid (phA) was designed complementary to the
translation site of the hhLIM gene, and transfected into
primary cardiac myocytes. It was demonstrated that hhLIM
antisense transcripts decreased hhLIM protein levels by
approximately 50% (Fig. 9A and B). Cardiomyocytes trans-
fected with antisense hhLIM expression plasmid (phA) or
pEGFP empty vector (as a control) were stimulated with
endothelin-1 for 24 h. Endothelin-1 increased cell surface
and BNP and a-actin expression in cultures transfected with
control plasmid, suggesting that the control plasmid alone
did not affect hypertrophic response. In contrast, overex-
pression of antisense hhLIM blocked the increase in cell
surface and BNP and a-actin expression induced by endo-
thelin-1 (Fig. 9C–F). Taken together, these data indicate
that inhibition of endogenous hhLIM expression can block
cardiomyocyte hypertrophy and suggest that hhLIM is a
necessary hypertrophic transducer.4. Discussion
Cardiac hypertrophy is defined as increase in ventric-
ular and/or sepal wall thickness caused by increased wall
tension or enhanced neural-hormonal stimulation. Al-
though a compensatory response initially normalizes wall
stress and augments pump function, prolonged cardiac
hypertrophy is a significant risk factor for the develop-
ment of future heart failure [2]. Both the increased wall
tension and neural-hormonal stimuli are thought to direct-
ly activate various membrane-bound receptors and signal
transduction cascades within cardiomyocytes, resulting in
the activation of immediate early genes such as c-jun, c-
fos, c-myc, erg-1, ANF, BNP, and h-MHC and skeletal a-
actin [11]. A number of transcription factors have been
implicated as direct mediators of hypertrophic gene ex-
pression including AP1, SP1, GATA-4, Nkx2.5 and hhLIM
protein [12].
The LIM domain defines a unique double zinc finger
structure that is highly conserved among proteins present inorganisms representing an extensive range of evolution.
They are thought to function as versatile protein modules,
capable of acting within diverse cellular contexts and in
multiple subcellular compartments [13]. Many LIM
domains have been shown to participate in direct protein–
protein interactions. Nuclear LIM proteins have long been
recognized as playing important roles in the control of gene
expression and cell fate determination. Although there is
little evidence to support direct DNA-binding activity of
LIM domains, nuclear magnetic resonance structural anal-
ysis of a LIM domain indicates that it is related to the zinc
fingers of the GATA family of transcription factors [4].
Recently, a new member of LIM family named hhLIM was
cloned; it has a typical LIM domain [5].
It is well known that endothelin-1 is a strong hypertro-
phic agonist. Cardiac hypertrophy marker genes including
BNP and a-actin were significantly up-regulated by endo-
thelin-1. The present results demonstrate that hhLIM
mRNA expression and the transcription of hhLIM promot-
er-enhancer luciferase gene were up-regulated by endothe-
lin-1, suggesting that hhLIM is an effector of hypertrophic
response. Although the results of the present studies clearly
implicate an important role for hhLIM in hypertrophic
signaling, direct experimental evidence linking hhLIM
transcription activity to the initiation and/or maintenance
of cardiac hypertrophy had not been demonstrated. C2C12
cells have been found to be suitable for stable transfection
with foreign cDNA and to express high levels of exogenous
proteins. So, C2C12 cells are useful for assessing the
functional effects of exogenous proteins. Here we utilized
hhLIM expression plasmids to examine the direct effects of
hhLIM on the hypertrophic response in cultured cardio-
myocytes and C2C12 cells (MT). Through these experi-
ments, we showed that overexpression of hhLIM was
capable of activating transcription at the BNP promoter,
inducing BNP gene expression, promoting the accumula-
tion of a-actin, and initiating the hypertrophic response in
cultured C2C12 cells and cardiomyocytes. These results
suggest that hhLIM protein is involved in cell hypertrophy.
There are a number of possible mechanisms whereby
hhLIM could alter the fate of cells. Thus, the LIM domains
of hhLIM could, theoretically, directly bind DNA and
modulate transcription of specific genes. From the results
of co-immunoprecipitation and immunofluorescence assays,
we found that hhLIM is a member of a family of cytosolic
LIM domain-containing proteins that interacts with the
cytoskeletal protein a-actin. In the absence of endothelin-
1 stimulation, hhLIM was diffusely distributed throughout
the cytoplasm, suggesting that hhLIM is a kind of cyto-
skeleton component. However, endothelin-1 stimulation of
C2C12 cells (MT) resulted in a redistribution of hhLIM
from the cytoplasm to the nucleus. Reporter gene assay
showed that hhLIM was a transcriptional co-activator of
BNP promoter. Together these results suggest that hhLIM
protein is involved in cardiac hypertrophy in response to
stimuli such as endothelin-1.
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hypertrophy, we generated an antisense hhLIM expression
plasmid to analyze the effects of hhLIM gene silencing on
hypertrophic response in cultured neonatal cardiomyocytes.
Antisense hhLIM overexpression blocks endothelin-induced
cardiomyocyte hypertrophy as determined by cell surface
area, BNP expression, and skeletal a-actin accumulation.
Overexpression of GFP alone did not down-regulate any of
these parameters, showing that these results were specific to
hhLIM gene silencing. These data indicate that a functional
hhLIM-dependent transcriptional pathway is required for
the efficient induction of the hypertrophic response in
cultured cardiomyocytes.
Altogether, the present results demonstrate that hhLIM-
dependent transcription is necessary for cardiomyocyte
hypertrophy induced by endothelin-1. Recently, a number
of mechanisms have been proposed whereby hhLIM might
induce cardiac-gene expression. First, hhLIM transcripts are
up-regulated by hypertrophic stimuli, which have the same
expression pattern as the cardiac hypertrophy gene BNP.
Their similar expression pattern and participation in the
functional process suggest that hhLIM may contribute to
cardiac hypertrophy. Second, we identified that hhLIM
could interact with other cardiac-expressed transcription
factors such as SRF, MEF-2, GATA-4 and Nkx2.5, each
of which is involved in regulating hypertrophic gene ex-
pression [7,14,15]. Here we show that overexpression of
hhLIM is capable of activating transcription of the BNP
promoter and promoting accumulation of BNP mRNA and
a-actin protein. These results suggest that hhLIM might
contribute to the signaling pathway triggered by endothelin-
1, stimulate expression of BNP and skeletal a-actin, and
induce cardiac hypertrophy. However, these data only show
that hhLIM is necessary for integrated signaling in response
to hypertrophic stimuli, but do not preclude the involvement
of other transcriptional regulatory factors in cellular hyper-
trophy. Indeed, a series of intracellular signaling pathways
and transcriptional factors have been shown to regulate the
hypertrophic response [15,16], suggesting that cardiac hy-
pertrophy is a complex process that requires the simulta-
neous orchestration of multiple parallel effectors to induce a
productive response. Determining how individual effector
proteins fit into this signaling web will be important for
understanding how the hypertrophic response is regulated.
In conclusion, we found that hhLIM gene expression in
cultured cardiomyocytes and C2C12 cells was regulated by
endothelin-1. hhLIM protein entered the nucleus when
cardiomyocytes and C2C12 cells (MT) are stimulated with
endothelin-1, and nuclear accumulation of hhLIM protein
might be associated with the cell hypertrophy. In the
cytoplasm, hhLIM interacts with skeletal a-actin and par-
ticipates in cytoskeletal organization. Overexpression of
hhLIM gene is sufficient to induce a great increase in
cardiac myocyte area and trigger the expression of cardiac
hypertrophic marker gene BNP and skeletal a-actin. Inhi-
bition of hhLIM expression by antisense transcripts blockedendothelin-induced expression of skeletal a-actin and BNP
genes. Altogether, our study suggests that an hhLIM-depen-
dent transcriptional pathway is necessary to induce the
hypertrophic response in cultured cardiomyocytes and
C2C12 cells (MT).Acknowledgements
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